The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California
The Oncology Institute, Inc. (TOI)
Company Research
Source: GlobeNewswire
CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) announced that they have received certification to begin administering Pluvicto therapy in their outpatient California radiation oncology practices. Pluvicto, a radiopharmaceutical used to treat certain types of metastatic prostate cancer, has previously been administered primarily in hospital settings. “We are ecstatic about the opportunity to offer this new therapeutic alternative to our patients,” said Dr. Geoffrey Geiger, Medical Director of Radiation Oncology at TOI. “This aligns perfectly with TOI’s mission to deliver state-of-the-art therapy in the community and provide value for our patients and payor partners.” Jeremy Castle, Chief Operations Officer, added, “The launch of our radiopharmaceutical program marks a significant step forward in our radiation oncology growth strategy. By providing this treatment in the outpatient setting, we can reduce the ne
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- The Oncology Institute Inc (TOI) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst ... [Yahoo! Finance]Yahoo! Finance
- The Oncology Institute Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc.Accesswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.Accesswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The OncologyAccesswire
TOI
Earnings
- 8/13/24 - Miss
TOI
Sec Filings
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- TOI's page on the SEC website